OSCR
Oscar Health, Inc. · Healthcare · Medical - Healthcare Plans
Momentum inputs (comparable managers):
holder breadth -5.6% ·
share flow -6.2% ·
net new positions -5.9%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 121 | +14 | 136.98M | $3.90B | +21 | −8 |
| Q1 2026 | 111 | -1 | 110.57M | $1.27B | +11 | −13 |
| Q4 2025 | 112 | -3 | 121.38M | $1.74B | +2 | −4 |
| Q3 2025 | 22 | +3 | 74.59M | $1.41B | +5 | −3 |
| Q2 2025 | 17 | -1 | 57.51M | $1.23B | +1 | −2 |
| Q1 2025 | 15 | -1 | 25.41M | $333.18M | +2 | −3 |
| Q4 2024 | 16 | -1 | 29.22M | $392.74M | +2 | −3 |
| Q3 2024 | 16 | +2 | 34.05M | $722.32M | +2 | — |
| Q2 2024 | 14 | — | 28.60M | $452.40M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 19.74M | — | $423.17M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passive) | 15.76M | — | $337.88M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 3 | State Street Global Advisors ✦ (passive) | 5.40M | -6.6% | $115.79M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 4.51M | -3.8% | $96.63M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 5 | Capital World Investors ✦ | 3.62M | 0.0% | $77.67M | 0.0% | Held | 5 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 2.01M | +35.6% | $43.05M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 1.46M | +53.8% | $31.40M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 1.37M | +89.3% | $29.30M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 910.70K | +208.2% | $19.53M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 10 | Baillie Gifford ✦ | 822.09K | 0.0% | $17.63M | 0.0% | Held | 5 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 680.36K | -79.5% | $14.59M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 12 | Millennium Management ✦ | 576.17K | -73.6% | $12.35M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 399.88K | — | $8.57M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 14 | AQR Capital Management ✦ | 190.05K | -6.4% | $4.07M | 0.0% | ▼ Trim | 5 | SEC ↗ ×5 |
| 15 | Marshall Wace ✦ | 29.20K | New | $626,069 | 0.0% | New | 1 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 23.51K | +101.1% | $504,140 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | Norges Bank ✦ (passive) | 16.72K | 0.0% | $358,434 | 0.0% | Held | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $626,069 | 0.0% |
Exited
| Glenview Capital | $10.47M | was 0.3% |
| Adage Capital Partners | $6.73M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 84.20K shares, $965 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 25.00K sh · $806,000
Officer · 958 sh · $30,129
Officer · 10.36K sh · $325,822
Officer · 9.09K sh · $285,943
Director · 31.42K sh · $988,222
Officer · 28.87K sh · $907,930
Director · 150.00K sh · $4.62M
Director · 600.00K sh · $18.20M
Officer · 18.75K sh · $595,125
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
1.7% of class · View original SEC filing ↗